Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

CardioVascular BioTherapeutics Submits FDA Application for ‘Fast Track’ Status for CVBT-141B, CVBT’s Biological Treatment for Diabetes Patients

February 3, 2011 By Bio-Medicine.Org

LAS VEGAS, Feb. 3, 2011 /PRNewswire/ — CardioVascular
BioTherapeutics, Inc. (Pink Sheets:
CVBT) today announced it has submitted an application to the
U.S. FDA to obtain “fast track” designation for CVBT-141B, its
biological therapy to treat ischemic diabetic wounds based on the
active ingredient fibroblast growth factor-1 (FGF-1).  The FDA
grants “fast track” designation to accelerate the development of
promising new therapies that treat a serious medical condition and
for which there are no available therapies that adequately address
the problem.

CVBT believes CVBT-141B meets the FDA’s criteria, as ischemic
diabetic wounds, if not successfully treated, can lead to
infection, sepsis, amputation, and death.  Even with
currently-available treatments, there are more than 80,000 foot
amputations per year in the diabetic patient population.
 CVBT-141B is targeted at reducing the suffering in the
diabetes community by closing ischemic diabetic wounds much more
rapidly, thereby halting the all-too-common progression to
infection, gangrene, amputation, and death.

CVBT’s CEO, Daniel C. Montano, stated, “This is a major
development for CVBT’s ischemic diabetic wound healing program as
well as for diabetes patients.  The Centers for Disease
Control and Prevention (CDC) reports that approximately 26 million
Americans suffer from diabetes, while published peer-reviewed
statistics indicate that 15% to 25% of these patients (3.9 million
to 6.5 million patients) will eventually develop a diabetic foot
wound at some point in their lifetime(i). Further, additional
published peer-reviewed statistics indicate that in any given year,
between 2% and 5% of diabetes patients (520,000 to 1.3 million
patients annually) will develop one of these wounds(ii). Ischemic
diabetic wounds are the most difficult of to heal. This is a
life-threatening health problem for which there

‘/>”/>

SOURCE

Related Articles Read More >

A photo of nitinol, a nickel-titanium alloy used for medical devices such as stents, heart valves, catheters and orthopedics.
What is nitinol and where is it used?
An image of Abbott's Infinity deep brain stimulation (DBS) implants and leads.
How Abbott developed the first-of-its-kind Infinity DBS system
Axoft Fleuron brain-computer interface BCI probe
Axoft makes Fleuron BCI material available for purchase, inks license deal with Stanford
An illustration showing the Edwards Lifesciences Sapien M3 transcatheter mitral valve replacement (TMVR) system's valve being placed in the heart. [Image courtesy of Edwards Lifesciences]
The top nitinol cardiac medtech news of 2025 (so far)
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe